$211 Million is the total value of ArchPoint Investors's 56 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 42.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GOOGL | Sell | ALPHABET INCcap stk cl a | $57,393,615 | -12.7% | 650,500 | -5.3% | 27.17% | +1.2% |
| AMZN | Sell | AMAZON COM INC | $14,931,420 | -37.6% | 177,755 | -16.0% | 7.07% | -27.6% |
| RXRX | Sell | RECURSION PHARMACEUTICALS INcl a | $8,593,766 | -27.6% | 1,114,626 | -0.1% | 4.07% | -16.1% |
| RGNX | Sell | REGENXBIO INC | $5,086,625 | -23.8% | 224,278 | -11.2% | 2.41% | -11.7% |
| XOP | Sell | SPDR SER TRs&p oilgas exp | $3,734,934 | +6.6% | 27,487 | -2.2% | 1.77% | +23.5% |
| AMLP | Sell | ALPS ETF TRalerian mlp | $1,814,987 | -25.0% | 47,675 | -28.0% | 0.86% | -13.1% |
| OIH | Sell | VANECK ETF TRUSToil services etf | $1,368,225 | +39.3% | 4,500 | -3.2% | 0.65% | +61.6% |
| ABCL | Sell | ABCELLERA BIOLOGICS INC | $1,165,507 | -80.9% | 115,055 | -81.4% | 0.55% | -77.8% |
| MOS | Sell | MOSAIC CO NEW | $921,270 | -58.6% | 21,000 | -54.3% | 0.44% | -52.0% |
| CPNG | Sell | COUPANG INCcl a | $485,430 | -27.2% | 33,000 | -17.5% | 0.23% | -15.4% |
| FB | Sell | META PLATFORMS INCcl a | $361,020 | -89.7% | 3,000 | -88.4% | 0.17% | -88.0% |
| DM | Sell | DESKTOP METAL INC | $44,472 | -57.6% | 32,700 | -19.7% | 0.02% | -51.2% |
| VBIV | Exit | VBI VACCINES INC CDA | $0 | – | -65,000 | -100.0% | -0.02% | – |
| LABP | Exit | LANDOS BIOPHARMA INC | $0 | – | -127,262 | -100.0% | -0.03% | – |
| ZY | Exit | ZYMERGEN INC | $0 | – | -34,000 | -100.0% | -0.04% | – |
| Exit | ASTRIA THERAPEUTICS INC | $0 | – | -24,331 | -100.0% | -0.09% | – | |
| GOOG | Exit | ALPHABET INCcap stk cl c | $0 | – | -3,100 | -100.0% | -0.12% | – |
| MMM | Exit | 3M CO | $0 | – | -3,000 | -100.0% | -0.14% | – |
| BTI | Exit | BRITISH AMERN TOB PLCsponsored adr | $0 | – | -18,686 | -100.0% | -0.28% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -92,500 | -100.0% | -0.36% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -168,725 | -100.0% | -4.69% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LA Z BOY INC | 42 | Q3 2023 | 24.1% |
| Thermo Fisher SCNTFC | 42 | Q3 2023 | 4.3% |
| Genuine Parts Co Com | 42 | Q3 2023 | 4.4% |
| Dorchester Minerals Lp Com Uni | 42 | Q3 2023 | 7.7% |
| CURTISS WRIGHT CORP | 42 | Q3 2023 | 3.2% |
| Activision Blizzard Inc Put Op | 42 | Q3 2023 | 3.4% |
| APPLE INC. | 42 | Q3 2023 | 3.8% |
| Cisco Systems Inc | 42 | Q3 2023 | 2.7% |
| Exxon Mobil Corporation | 42 | Q3 2023 | 0.5% |
| Enterprise Products Partners L | 41 | Q3 2023 | 1.9% |
View ArchPoint Investors's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
View ArchPoint Investors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.